<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font15">for </span>
   <span class="font14">with </span>
   <span class="font13">The </span>
   <span class="font13">that </span>
   <span class="font12">drug </span>
   <span class="font12">are </span>
   <span class="font12">antiviral </span>
   <span class="font12">NPs </span>
   <span class="font11">HIV </span>
   <span class="font11">[]. </span>
   <span class="font11">viral </span>
   <span class="font11">have </span>
   <span class="font11">can </span>
   <span class="font11">delivery </span>
   <span class="font11">from </span>
   <span class="font11">been </span>
   <span class="font11">cell </span>
   <span class="font11">virus </span>
   <span class="font11">nanoparticles </span>
   <span class="font11">has </span>
   <span class="font11">through </span>
   <span class="font11">between </span>
   <span class="font10">size </span>
   <span class="font10">treatment </span>
   <span class="font10">also </span>
   <span class="font10">{background </span>
   <span class="font10">into </span>
   <span class="font10">this </span>
   <span class="font10">which </span>
   <span class="font10">loaded </span>
   <span class="font10">al. </span>
   <span class="font10">different </span>
   <span class="font10">[], </span>
   <span class="font10">cells </span>
   <span class="font10">drugs </span>
   <span class="font10">not </span>
   <span class="font10">HSV- </span>
   <span class="font10">based </span>
   <span class="font10">their </span>
   <span class="font10">using </span>
   <span class="font10">viruses </span>
   <span class="font10">BBB </span>
   <span class="font10">used </span>
   <span class="font10">Drug </span>
   <span class="font10">margin </span>
   <span class="font10">nm; </span>
   <span class="font10">DNA </span>
   <span class="font10">surface </span>
   <span class="font10">therapy </span>
   <span class="font10">{border-style </span>
   <span class="font10">ACV </span>
   <span class="font10">online: </span>
   <span class="font10">studies </span>
   <span class="font10">vitro </span>
   <span class="font10">activity </span>
   <span class="font10">against </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">brain </span>
   <span class="font10">px;} </span>
   <span class="font10">were </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Antiviral </span>
   <span class="font10">biological </span>
   <span class="font10">cellular </span>
   <span class="font10">its </span>
   <span class="font10">most </span>
   <span class="font10">than </span>
   <span class="font10">these </span>
   <span class="font10">HIV- </span>
   <span class="font10">but </span>
   <span class="font10">nanotechnology </span>
   <span class="font10">review </span>
   <span class="font10">HSV </span>
   <span class="font10">Nanoparticles </span>
   <span class="font10">active </span>
   <span class="font10">being </span>
   <span class="font10">results </span>
   <span class="font10">vivo </span>
   <span class="font10">after </span>
   <span class="font10">clinical </span>
   <span class="font10">human </span>
   <span class="font10">infection </span>
   <span class="font10">influenza </span>
   <span class="font10">more </span>
   <span class="font10">new </span>
   <span class="font10">two </span>
   <span class="font10">use </span>
   <span class="font10">was </span>
   <span class="font10">Î¶-potential </span>
   <span class="font10">AZT </span>
   <span class="font10">PLGA </span>
   <span class="font10">complex </span>
   <span class="font10">hepatitis </span>
   <span class="font10">host </span>
   <span class="font10">mechanism </span>
   <span class="font10">nanosystems </span>
   <span class="font10">only </span>
   <span class="font10">proved </span>
   <span class="font10">such </span>
   <span class="font10">targeted </span>
   <span class="font10">authors </span>
   <span class="font10">cells, </span>
   <span class="font10">due </span>
   <span class="font10">free </span>
   <span class="font10">impact </span>
   <span class="font10">oral </span>
   <span class="font10">replication </span>
   <span class="font10">reverse </span>
   <span class="font10">skin </span>
   <span class="font10">some </span>
   <span class="font10">Table </span>
   <span class="font10">across </span>
   <span class="font10">around </span>
   <span class="font10">both </span>
   <span class="font10">could </span>
   <span class="font10">formulation </span>
   <span class="font10">high </span>
   <span class="font10">intracellular </span>
   <span class="font10">large </span>
   <span class="font10">mV; </span>
   <span class="font10">mechanisms </span>
   <span class="font10">membrane </span>
   <span class="font10">order </span>
   <span class="font10">particles </span>
   <span class="font10">penetration </span>
   <span class="font10">properties </span>
   <span class="font10">specific </span>
   <span class="font10">spherical </span>
   <span class="font10">systems </span>
   <span class="font10">toxicity </span>
   <span class="font10">transcriptase </span>
   <span class="font10">Delivery </span>
   <span class="font10">Pharm. </span>
   <span class="font10">all </span>
   <span class="font10">barriers </span>
   <span class="font10">blood </span>
   <span class="font10">current </span>
   <span class="font10">described </span>
   <span class="font10">diameter </span>
   <span class="font10">diseases </span>
   <span class="font10">enhanced </span>
   <span class="font10">first </span>
   <span class="font10">form </span>
   <span class="font10">found </span>
   <span class="font10">important </span>
   <span class="font10">incorporated </span>
   <span class="font10">infections </span>
   <span class="font10">inhibitors </span>
   <span class="font10">less </span>
   <span class="font10">may </span>
   <span class="font10">nanogels </span>
   <span class="font10">other </span>
   <span class="font10">potential </span>
   <span class="font10">protein </span>
   <span class="font10">therapeutic </span>
   <span class="font10">three </span>
   <span class="font10">transport </span>
   <span class="font10">Figure </span>
   <span class="font10">GCV </span>
   <span class="font10">HCV </span>
   <span class="font10">RNA </span>
   <span class="font10">acid </span>
   <span class="font10">bioavailability </span>
   <span class="font10">concentrations </span>
   <span class="font10">costs </span>
   <span class="font10">effective </span>
   <span class="font10">features </span>
   <span class="font10">health </span>
   <span class="font10">herpes </span>
   <span class="font10">infectious </span>
   <span class="font10">lipid </span>
   <span class="font10">major </span>
   <span class="font10">molecules </span>
   <span class="font10">our </span>
   <span class="font10">presented </span>
   <span class="font10">resistance </span>
   <span class="font10">several </span>
   <span class="font10">targeting </span>
   <span class="font10">under </span>
   <span class="font10">uptake </span>
   <span class="font10">vaccine </span>
   <span class="font10">(e.g., </span>
   <span class="font10">NFV </span>
   <span class="font10">November </span>
   <span class="font10">Rev. </span>
   <span class="font10">Spherical </span>
   <span class="font10">This </span>
   <span class="font10">Virus </span>
   <span class="font10">ability </span>
   <span class="font10">absorption </span>
   <span class="font10">agents </span>
   <span class="font10">approved </span>
   <span class="font10">available </span>
   <span class="font10">barrier </span>
   <span class="font10">compared </span>
   <span class="font10">considered </span>
   <span class="font10">developed </span>
   <span class="font10">drug, </span>
   <span class="font10">economic </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">efflux </span>
   <span class="font10">encapsulated </span>
   <span class="font10">entry </span>
   <span class="font10">global </span>
   <span class="font10">improved </span>
   <span class="font10">include </span>
   <span class="font10">increased </span>
   <span class="font10">kinase </span>
   <span class="font10">medical </span>
   <span class="font10">mucus </span>
   <span class="font10">nm, </span>
   <span class="font10">px; </span>
   <span class="font10">reduced </span>
   <span class="font10">related </span>
   <span class="font10">responsible </span>
   <span class="font10">small </span>
   <span class="font10">solid </span>
   <span class="font10">stable </span>
   <span class="font10">study </span>
   <span class="font10">target </span>
   <span class="font10">there </span>
   <span class="font10">they </span>
   <span class="font10">types </span>
   <span class="font10">virus, </span>
   <span class="font10">{font-family </span>
   <span class="font10">January </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Res. </span>
   <span class="font10">Section </span>
   <span class="font10">These </span>
   <span class="font10">Viral </span>
   <span class="font10">[,]. </span>
   <span class="font10">average </span>
   <span class="font10">chronic </span>
   <span class="font10">data </span>
   <span class="font10">development </span>
   <span class="font10">during </span>
   <span class="font10">endothelial </span>
   <span class="font10">font-size </span>
   <span class="font10">highly </span>
   <span class="font10">inhibitor </span>
   <span class="font10">must </span>
   <span class="font10">number </span>
   <span class="font10">possible </span>
   <span class="font10">release </span>
   <span class="font10">side </span>
   <span class="font10">social </span>
   <span class="font10">sodium </span>
   <span class="font10">still </span>
   <span class="font10">structure </span>
   <span class="font10">studied </span>
   <span class="font10">therefore </span>
   <span class="font10">thymidine </span>
   <span class="font10">when </span>
   <span class="font10">According </span>
   <span class="font10">Also, </span>
   <span class="font10">EFV </span>
   <span class="font10">ENF </span>
   <span class="font10">HPAC </span>
   <span class="font10">Human </span>
   <span class="font10">LAM </span>
   <span class="font10">Med. </span>
   <span class="font10">NPs; </span>
   <span class="font10">Nanomaterials </span>
   <span class="font10">Opin. </span>
   <span class="font10">Res../s--- </span>
   <span class="font10">Treatment </span>
   <span class="font10">[]; </span>
   <span class="font10">access </span>
   <span class="font10">antivirals </span>
   <span class="font10">approaches </span>
   <span class="font10">challenges </span>
   <span class="font10">classes </span>
   <span class="font10">combination </span>
   <span class="font10">conjugated </span>
   <span class="font10">controlled </span>
   <span class="font10">cost </span>
   <span class="font10">currently </span>
   <span class="font10">design </span>
   <span class="font10">designed </span>
   <span class="font10">disease </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">efficiency </span>
   <span class="font10">either </span>
   <span class="font10">followed </span>
   <span class="font10">functionalized </span>
   <span class="font10">higher </span>
   <span class="font10">issues </span>
   <span class="font10">lamivudine </span>
   <span class="font10">leading </span>
   <span class="font10">limitations </span>
   <span class="font10">low </span>
   <span class="font10">materials </span>
   <span class="font10">mentioned </span>
   <span class="font10">model </span>
   <span class="font10">namely </span>
   <span class="font10">nanomaterials </span>
   <span class="font10">nanoparticles; </span>
   <span class="font10">obtained </span>
   <span class="font10">patients </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">prepared </span>
   <span class="font10">promising </span>
   <span class="font10">provide </span>
   <span class="font10">regarding </span>
   <span class="font10">selective </span>
   <span class="font10">should </span>
   <span class="font10">since </span>
   <span class="font10">strategies </span>
   <span class="font10">stratum </span>
   <span class="font10">substances </span>
   <span class="font10">sustained </span>
   <span class="font10">synthesized </span>
   <span class="font10">therapy. </span>
   <span class="font10">those </span>
   <span class="font10">topical </span>
   <span class="font10">transporters </span>
   <span class="font10">type </span>
   <span class="font10">values </span>
   <span class="font10">virus; </span>
   <span class="font10">(%) </span>
   <span class="font10">... </span>
   <span class="font10">ATV </span>
   <span class="font10">Barrier </span>
   <span class="font10">Biopharm../j.ejpb... </span>
   <span class="font10">Cells </span>
   <span class="font10">Chem. </span>
   <span class="font10">Clin. </span>
   <span class="font10">HIV/AIDS </span>
   <span class="font10">Infection </span>
   <span class="font10">Lactoferrin </span>
   <span class="font10">Lipid </span>
   <span class="font10">Review </span>
   <span class="font10">Vero </span>
   <span class="font10">Viruses </span>
   <span class="font10">acid; </span>
   <span class="font10">acts </span>
   <span class="font10">adhesion </span>
   <span class="font10">because </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">called </span>
   <span class="font10">care </span>
   <span class="font10">carriers </span>
   <span class="font10">charged </span>
   <span class="font10">containing </span>
   <span class="font10">corneum </span>
   <span class="font10">dependent </span>
   <span class="font10">directly </span>
   <span class="font10">exhibit </span>
   <span class="font10">following </span>
   <span class="font10">further </span>
   <span class="font10">gold </span>
   <span class="font10">good </span>
   <span class="font10">great </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">improve </span>
   <span class="font10">includes </span>
   <span class="font10">including </span>
   <span class="font10">incorporation </span>
   <span class="font10">increase </span>
   <span class="font10">infected </span>
   <span class="font10">influence </span>
   <span class="font10">interaction </span>
   <span class="font10">interactions </span>
   <span class="font10">latent </span>
   <span class="font10">layer </span>
   <span class="font10">level </span>
   <span class="font10">like </span>
   <span class="font10">literature </span>
   <span class="font10">mainly </span>
   <span class="font10">mutations </span>
   <span class="font10">nano-based </span>
   <span class="font10">numerous </span>
   <span class="font10">particles; </span>
   <span class="font10">passive </span>
   <span class="font10">penetrate </span>
   <span class="font10">permeability </span>
   <span class="font10">poly </span>
   <span class="font10">polymeric </span>
   <span class="font10">produced </span>
   <span class="font10">protease </span>
   <span class="font10">proteins </span>
   <span class="font10">range </span>
   <span class="font10">reduce </span>
   <span class="font10">same </span>
   <span class="font10">showed </span>
   <span class="font10">siRNA </span>
   <span class="font10">single </span>
   <span class="font10">smooth </span>
   <span class="font10">solid; </span>
   <span class="font10">summarized </span>
   <span class="font10">system </span>
   <span class="font10">tested </span>
   <span class="font10">thus </span>
   <span class="font10">time </span>
   <span class="font10">variety </span>
   <span class="font10">very </span>
   <span class="font10">virucidal </span>
   <span class="font10">vitro; </span>
   <span class="font10">where </span>
   <span class="font10">within </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.collab: </span>
   <span class="font10">All </span>
   <span class="font10">Another </span>
   <span class="font10">Antiretroviral </span>
   <span class="font10">Based </span>
   <span class="font10">CCR </span>
   <span class="font10">Cell </span>
   <span class="font10">Combination </span>
   <span class="font10">Designed </span>
   <span class="font10">Economic </span>
   <span class="font10">Gastroenteritis </span>
   <span class="font10">Herpes </span>
   <span class="font10">Influenza </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">LNPs </span>
   <span class="font10">Loaded </span>
   <span class="font10">MCV </span>
   <span class="font10">More </span>
   <span class="font10">Nanotechnology </span>
   <span class="font10">Non-toxic </span>
   <span class="font10">PEO-PCL </span>
   <span class="font10">PIs </span>
   <span class="font10">Particle </span>
   <span class="font10">Reverse </span>
   <span class="font10">SLNs </span>
   <span class="font10">SQV </span>
   <span class="font10">Sargassum </span>
   <span class="font10">Simplex </span>
   <span class="font10">Tenofovir </span>
   <span class="font10">There </span>
   <span class="font10">Type </span>
   <span class="font10">Uniformly </span>
   <span class="font10">[,,] </span>
   <span class="font10">[,] </span>
   <span class="font10">about </span>
   <span class="font10">above-mentioned </span>
   <span class="font10">act </span>
   <span class="font10">acyclovir </span>
   <span class="font10">administration </span>
   <span class="font10">administration, </span>
   <span class="font10">advanced </span>
   <span class="font10">adverse </span>
   <span class="font10">and/or </span>
   <span class="font10">another </span>
   <span class="font10">anti-HIV </span>
   <span class="font10">associated </span>
   <span class="font10">barriers, </span>
   <span class="font10">become </span>
   <span class="font10">binding </span>
   <span class="font10">blood-brain </span>
   <span class="font10">bold </span>
   <span class="font10">briefly </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cancer </span>
   <span class="font10">cases, </span>
   <span class="font10">caused </span>
   <span class="font10">cells. </span>
   <span class="font10">chemical </span>
   <span class="font10">coated </span>
   <span class="font10">common </span>
   <span class="font10">compounds </span>
   <span class="font10">contact </span>
   <span class="font10">coumestrol </span>
   <span class="font10">courier; </span>
   <span class="font10">deliver </span>
   <span class="font10">delivery, </span>
   <span class="font10">determined </span>
   <span class="font10">developing </span>
   <span class="font10">diagnostic </span>
   <span class="font10">diphosphate </span>
   <span class="font10">does </span>
   <span class="font10">doses </span>
   <span class="font10">drugs, </span>
   <span class="font10">each </span>
   <span class="font10">early </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">encapsulation </span>
   <span class="font10">encephalitis </span>
   <span class="font10">endocytosis </span>
   <span class="font10">epithelial </span>
   <span class="font10">even </span>
   <span class="font10">example </span>
   <span class="font10">example, </span>
   <span class="font10">fact </span>
   <span class="font10">fluid </span>
   <span class="font10">future </span>
   <span class="font10">gene </span>
   <span class="font10">hybrid </span>
   <span class="font10">immune </span>
   <span class="font10">included </span>
   <span class="font10">incorporates </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">infections, </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitors; </span>
   <span class="font10">innovative </span>
   <span class="font10">inside </span>
   <span class="font10">interact </span>
   <span class="font10">intestinal </span>
   <span class="font10">issue </span>
   <span class="font10">known </span>
   <span class="font10">last </span>
   <span class="font10">layers </span>
   <span class="font10">linked </span>
   <span class="font10">lipophilic </span>
   <span class="font10">liposomes, </span>
   <span class="font10">liver </span>
   <span class="font10">local </span>
   <span class="font10">magnetic </span>
   <span class="font10">manuscript. </span>
   <span class="font10">mediated </span>
   <span class="font10">metabolic </span>
   <span class="font10">methods </span>
   <span class="font10">mice; </span>
   <span class="font10">mucosa. </span>
   <span class="font10">namely: </span>
   <span class="font10">nanoemulsions </span>
   <span class="font10">nanomedicine </span>
   <span class="font10">nanoparticulate </span>
   <span class="font10">nanoplatforms </span>
   <span class="font10">novel </span>
   <span class="font10">nucleoside </span>
   <span class="font10">nucleotide </span>
   <span class="font10">offer </span>
   <span class="font10">one </span>
   <span class="font10">out </span>
   <span class="font10">overcome </span>
   <span class="font10">part </span>
   <span class="font10">pass </span>
   <span class="font10">patient </span>
   <span class="font10">per </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">physico-chemical </span>
   <span class="font10">polydisperse </span>
   <span class="font10">polymerase </span>
   <span class="font10">polymers </span>
   <span class="font10">practice, </span>
   <span class="font10">preparation </span>
   <span class="font10">prepare </span>
   <span class="font10">present </span>
   <span class="font10">prevent </span>
   <span class="font10">preventing </span>
   <span class="font10">product </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">published </span>
   <span class="font10">receptor </span>
   <span class="font10">represented </span>
   <span class="font10">resistant </span>
   <span class="font10">respiratory </span>
   <span class="font10">response </span>
   <span class="font10">savings </span>
   <span class="font10">selenium </span>
   <span class="font10">seven </span>
   <span class="font10">shape </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">simplex </span>
   <span class="font10">site </span>
   <span class="font10">strand </span>
   <span class="font10">superior </span>
   <span class="font10">synthesis </span>
   <span class="font10">tenofovir </span>
   <span class="font10">then </span>
   <span class="font10">therapy, </span>
   <span class="font10">tools </span>
   <span class="font10">translated </span>
   <span class="font10">treated </span>
   <span class="font10">via </span>
   <span class="font10">viability </span>
   <span class="font10">viruses, </span>
   <span class="font10">vitro, </span>
   <span class="font10">well </span>
   <span class="font10">while </span>
   <span class="font10">will </span>
  </p>
 </body>
</html>
